Shanghai Pharmaceuticals Holding (601607.SH): Metoprolol succinate tablets passed the generic drug consistency evaluation.

Shanghai Pharmaceuticals Holding (601607.SH) announced that recently, its subsidiary Changzhou Pharmaceutical Factory Co., Ltd. (referred to as "Changzhou Pharmaceutical Factory") received the "Drug Supplementary Application Approval Notice" (Notice No.: 2025B05883) issued by the National Medical Products Administration. The drug, Sotalol Hydrochloride Tablets, has passed the evaluation of generic drug quality and efficacy consistency. Sotalol Hydrochloride Tablets are mainly used for: 1. Conversion and prevention of supraventricular tachycardia, especially atrioventricular nodal reentrant tachycardia, and can also be used for pre-excitation syndrome with supraventricular tachycardia. 2. Atrial flutter, atrial fibrillation. 3. Various ventricular arrhythmias, including ventricular premature beats, sustained and non-sustained ventricular tachycardia. 4. Acute myocardial infarction complicated by severe arrhythmias.